There is a high prevalence of heart failure (HF) worldwide, which has significant consequences for healthcare costs, patient death and quality of life. Therefore, there has been much focus on finding and using biomarkers for early diagnosis, prognostication and therapy of HF. This overview of the research presents a thorough examination of the current state of HF biomarkers and their many uses.
View Article and Find Full Text PDFAnnually, 1.5 million cases of hepatitis A infection occur worldwide. The United Arab Emirates (U.
View Article and Find Full Text PDF